Core Viewpoint - Medline Inc. is conducting a secondary offering of 75,000,000 shares of its Class A common stock at a public price of $41.00 per share, with an additional option for underwriters to purchase up to 11,250,000 shares [1] Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, serving all points of care globally [6] - The company is headquartered in Northfield, Illinois, employs over 45,000 people, and operates in more than 100 countries [6] Offering Details - The offering is being made by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC, and a subsidiary of the Abu Dhabi Investment Authority [1] - Medline will not sell any shares in this offering and will not receive any proceeds from the sale [2] - The offering is expected to close on March 10, 2026, subject to customary closing conditions [1] Underwriters - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan are acting as global coordinators and joint bookrunning managers for the offering [3] - A wide range of other financial institutions are involved as bookrunning managers and co-managers [3]

Core Viewpoint - VEON Ltd. announced the pricing of a public offering of 12,100,000 common shares held by VEON Amsterdam B.V. and 400,000 common shares from other selling shareholders at a price of USD 10.50 per share, with an additional option for underwriters to purchase up to 1,875,000 shares [1][2] Group 1: Offering Details - The public offering is set to close on February 2, 2026, pending customary closing conditions [2] - The offering is being managed by Morgan Stanley, Barclays, Cantor, and Rothschild & Co as joint book-running managers, with Benchmark, StoneX Company, and Northland Capital Markets as co-managers [2] Group 2: Company Background - VEON is a digital operator providing connectivity and digital services to nearly 150 million connectivity users and over 140 million digital users across five countries [5] - Kyivstar Group Ltd. operates as Ukraine's leading digital operator, offering a range of services including mobile and fixed-line voice and data, ride-hailing, e-health, digital TV, and enterprise solutions [6] Group 3: Investment Plans - Together with VEON, Kyivstar plans to invest USD 1 billion in Ukraine from 2023 to 2027, focusing on social investments in infrastructure, technological development, charitable donations, and strategic acquisitions [7]

As filed with the Securities and Exchange Commission on January 15, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRINITY BIOTECH PLC (Exact name of registrant as specified in its charter) (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer Ireland 2835 Not Applicable incorporation or organization) Classification Code Number) Identification Number) IDA Business Park Bray, County Wicklow, ...

Core Viewpoint - Holley Performance Brands has announced a secondary offering of 14,000,000 shares of its common stock at a price of $2.75 per share, with a 30-day option for underwriters to purchase an additional 2,100,000 shares [1] Group 1: Offering Details - The offering is being conducted by a selling stockholder controlled by Sentinel Capital Partners, and all net proceeds will go to the selling stockholder, with no shares being sold by the company [1] - The offering is expected to close on September 12, 2025, pending customary closing conditions [1] Group 2: Underwriters - J.P. Morgan and Jefferies are acting as lead book-running managers for the offering, while William Blair and Canaccord Genuity are serving as joint book-running managers [2] Group 3: Company Overview - Holley Performance Brands specializes in the design, manufacturing, and marketing of high-performance products for automotive enthusiasts, managing a portfolio of iconic brands [7] - The company focuses on four consumer verticals: Domestic Muscle, Modern Truck & Off-Road, Euro & Import, and Safety & Racing, aiming to impact the automotive aftermarket industry [8]

Core Viewpoint - Waystar Holding Corp. announced a secondary offering of 18,000,000 shares of common stock by certain investment funds, including EQT AB, Bain Capital, and Canada Pension Plan Investment Board, with J.P. Morgan acting as the underwriter [1][2]. Company Overview - Waystar is a provider of healthcare payments software, serving approximately 30,000 clients and over 1 million distinct providers, including 16 of the top 20 institutions on the U.S. News Best Hospitals list [5]. - The company's platform processes over 6 billion healthcare payment transactions annually, amounting to over $1.8 trillion in gross claims, covering approximately 50% of U.S. patients [5]. Offering Details - The shares will be offered to the public at a fixed price, which may change without notice, and Waystar will not receive any proceeds from this offering [2][3]. - A registration statement on Form S-3 has been filed with the SEC and has become effective, allowing the offering to proceed [3][4].

Core Insights - A secondary offering from a publicly traded regional bank may indicate financial distress, suggesting the need for additional cash to cover losses from its loan portfolio [1] Group 1 - Secondary offerings are often viewed as a negative signal in the financial markets, particularly for regional banks [1] - The financial world operates under the belief that markets are efficient, with stock prices reflecting their true value [1] - Profitable investment opportunities are typically found in stocks that are less followed by average investors or those that do not accurately represent current market opportunities [1]

Group 1 - dLocal Limited announced a secondary offering of 15,000,000 Class A common shares at a price of $12.75 per share, with no proceeds going to the company [1] - The offering is expected to close on September 5, 2025, subject to customary closing conditions [1] - Underwriters have a 30-day option to purchase an additional 2,250,000 Class A common shares from the Selling Shareholder at the public offering price [1] Group 2 - The offering is being managed by an underwriting group led by J.P. Morgan, Goldman Sachs & Co. LLC, and Morgan Stanley, with BTG Pactual and Citigroup as joint bookrunners [2] - dLocal has filed an automatically effective shelf registration statement with the SEC for the offering [3] Group 3 - dLocal operates a technology-first payments platform that connects global enterprise merchants with consumers in over 40 emerging market countries across Africa, Asia, and Latin America [5] - The "One dLocal" platform allows global companies to manage payments, pay-outs, and fund settlements without needing multiple local entities or payment processors [5]

Core Viewpoint - dLocal Limited has initiated a secondary offering of 15,000,000 Class A common shares, with no proceeds going to the company itself [1] Group 1: Offering Details - The offering is led by an entity associated with General Atlantic, and dLocal will not sell any shares in this offering [1] - The Selling Shareholder plans to provide underwriters with a 30-day option to purchase an additional 2,250,000 Class A common shares at the public offering price [2] - The underwriting group includes J.P. Morgan, Goldman Sachs & Co. LLC, and Morgan Stanley as global coordinators and joint bookrunners, along with BTG Pactual and Citigroup as joint bookrunners [2] Group 2: Regulatory Information - dLocal has filed an automatically effective shelf registration statement with the SEC for this offering [3] - Interested investors are encouraged to read the prospectus and related documents filed with the SEC for comprehensive information [3] Group 3: Company Overview - dLocal operates a technology-first payments platform that facilitates local payments in emerging markets, connecting global merchants with consumers in over 40 countries across Africa, Asia, and Latin America [5] - The "One dLocal" platform allows global companies to manage payments, payouts, and fund settlements without needing multiple local entities or payment processors [5]

Core Viewpoint - BrightSpring Health Services, Inc. announced the pricing of a secondary offering of 14,000,000 shares at $21.75 per share, with proceeds going to the selling stockholders, including KKR affiliates and management members [1] Group 1: Offering Details - The offering is underwritten and will close on June 12, 2025, subject to customary closing conditions [1] - The KKR Selling Stockholder has granted underwriters a 30-day option to purchase an additional 2,100,000 shares [1] - No shares are being sold by BrightSpring itself in this offering [1] Group 2: Underwriters and Managers - Goldman Sachs & Co. LLC, BofA Securities, Jefferies, and Morgan Stanley & Co. LLC are the lead book-running managers for the offering [2] - KKR Capital Markets LLC is acting as the lead managing agent [2] - A number of other firms are participating as bookrunners and co-managers for the offering [2] Group 3: Registration and Compliance - A shelf registration statement was filed with the SEC on June 10, 2025, and became effective upon filing [3] - The offering will be made only by means of a prospectus supplement and accompanying prospectus [4]

Core Viewpoint - BrightSpring Health Services, Inc. announced a secondary offering of 14,000,000 shares of common stock by certain stockholders, including affiliates of Kohlberg Kravis Roberts & Co. L.P. [1] Group 1: Offering Details - The offering will be conducted under a shelf registration statement filed with the SEC, and no shares are being sold by BrightSpring itself [1][3] - The KKR Selling Stockholder plans to grant underwriters a 30-day option to purchase an additional 2,100,000 shares [1] - Goldman Sachs & Co. LLC and BofA Securities are the lead book-running managers for the offering, with KKR Capital Markets LLC acting as the lead managing agent [2] Group 2: Registration and Prospectus - A shelf registration statement on Form S-3 was filed with the SEC on June 10, 2025, and became effective upon filing [3] - The offering will be made only by means of a prospectus supplement and accompanying prospectus [4]